Summary
Highlights
Dr. Lily Johnston, a vascular surgeon, explains that plaque silently builds in arteries, posing a significant risk of stroke, heart attack, and limb loss. She points out that many people are unaware of this danger until it's too late. Dr. Johnston emphasizes that surgical intervention for advanced arterial disease is akin to treating stage four cancer, highlighting the critical need for earlier diagnosis and prevention.
The discussion shifts to the goal of maintaining 'healthspan' rather than solely focusing on 'lifespan'. Dr. Johnston shares a poignant story of a patient who became suicidal after a second stroke due to inability to care for himself, underscoring the importance of preventing debilitating events caused by advanced arterial disease. The aim is to prevent disability and reliance on others, which can significantly impact quality of life, even in old age.
The conversation addresses the possibility of plaque reversal, with Dr. Johnston affirming that it is indeed possible, though stabilization is often the more achievable and equally important goal. She explains that while reversing plaque intuitively feels better, stabilizing it offers significant outcome benefits. They discuss the variability and reliability of CINT (Carotid Intima-Media Thickness) scans, with Dr. Johnston praising Dr. Todd Eldridge's rigorous methods for making CINT a reliable tool for indicating inflammation in the artery wall.
Dr. Johnston explains that a coronary calcium score (CAC) is a good screening tool but not ideal for monitoring disease progression, as it primarily indicates stable, calcified plaque. She notes that an increase in calcium score can be misleading, as it might represent the stabilization of soft plaque rather than disease progression. The discussion then moves to CCTA (coronary CT angiogram) as a more comprehensive tool, capable of detecting soft, vulnerable plaque that is not visible on a standard calcium score and is a major cause of serious cardiac events.
The segment highlights how artificial intelligence (AI) has revolutionized the interpretation of CCTA scans. In the past, human interpretation of CCTA often focused on the degree of arterial narrowing (plumbing), potentially missing crucial information about overall plaque burden and its composition. AI allows for a more detailed quantitative analysis, enabling doctors to assess the total plaque volume, its distribution, and the vulnerability of soft plaque, which is critical for prevention and personalized treatment strategies.
The discussion explores strategies for motivating younger patients to embrace preventative measures, emphasizing that fear is not an effective long-term motivator. Dr. Johnston suggests starting with small, achievable changes that restore hope and build trust. She advocates for addressing immediate concerns like energy levels, joint pain, or appearance, which resonate more with younger individuals than distant health threats. This approach helps patients gain confidence and gradually adopt more significant lifestyle changes, including nutrition, movement, stress management, and sleep optimization.
Dr. Johnston and the interviewer briefly touch upon the complexity of plaque formation, suggesting that different underlying conditions like inflammation, inherited dyslipidemias (e.g., high Lp(a), familial hypercholesterolemia), and toxic exposures (e.g., smoking, microplastics) might lead to plaque through different disease processes. They propose future discussions on how these diverse pathways contribute to atherosclerosis and how they can be specifically targeted for prevention and treatment.